People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc. | — | Biotechnology | Series B | $51.7M | $132.2M | 2023 |
Debra M White at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Debra M White on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis M McGrath | 1 | 5 |
| Stanley N. Lapidus | 1 | 4 |
| Lishan Aklog | 1 | 4 |
| Jacque J. Sokolov | 1 | 4 |
| James L Cox | 1 | 3 |
| Michael A. Gordon | 1 | 2 |
| Debra J. White | 1 | 2 |
| Ronald M. Sparks | 1 | 2 |
| Shaun M. O'Neil | 1 | 2 |
| DENNIS A. MATHEIS | 1 | 1 |
| Stanley L Lapidus | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.